Primary Site >> Colorectal Cancer
Gene >> CCSAP
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: A putatively new antigen (CSAp) associated with gastrointestinal and ovarian neoplasia. PMID: 407152 |
Ref: Further characterization of CSAp, an antigen associated with gastrointestinal and ovarian tumors. PMID: 81713 |
Ref: Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides. PMID: 6164726 |
Ref: Colon-specific antigen-p (CSAp). II. Further characterization in colorectal and pancreatic cancer. PMID: 6807529 |
Ref: Isolation and partial characterization of a 700 kilodalton human colon carcinoma associated antigen. PMID: 6616431 Ref: Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein. PMID: 6883374 |
Ref: Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTA. PMID: 6442455 |
Ref: Production of monoclonal antibody SP-21 to colon-ovarian tumor antigen, COTA. PMID: 3522411 |
Ref: A comparison of monoclonal antibodies against distinct colon tumor-associated antigens in immunohistochemistry and in tumor localization. PMID: 3298170 |
Ref: The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. PMID: 1652355 Ref: Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p. PMID: 1998972 |
Ref: Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. PMID: 9074529 Ref: Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. PMID: 9247292 |
Ref: Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy. PMID: 12743424 |